Professor David Price

Page 21 of 93 Results 201 to 210 of 923

Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
2022 - Published
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Deniz, Y., Siddiqui, S., Rowe, P.
AMCP Nexus 2022
Contributions to Conferences: Abstracts
Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study
2022 - Published
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
CHEST 2022, pp. A28-A32
Contributions to Journals: Abstracts
- [ONLINE] https://www.sciencedirect.com/science/article/pii/S0012369222013800
- [ONLINE] DOI: https://doi.org/10.1016/j.chest.2022.08.020
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/9b3b2a62-b22e-422c-9d7c-1a270e9e99f1/download
Clinical Review: The suggested management pathway for urticaria in primary care
2022 - Published
Ryan, D., Tanno, L. K., Angier, L., Clark, E., Price, D., Zuberbier, T., Maurer, M.
Clinical and Translational Allergy, vol. 12, no. 10, e12195
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1002/clt2.12195
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/8fef3de6-092e-4705-9991-0b739e2906de/download
Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study
2022 - Published
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
CHEST Annual Meeting, pp. A23-A27
Contributions to Journals: Abstracts
- [ONLINE] DOI: https://doi.org/10.1016/j.chest.2022.08.019
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/2f35682b-2389-47c1-b2b9-60b74bc0b141/download
Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort
2022 - Published
Price, D., Hancock, K., Doan, J., Taher, S. W., Muhwa, C. J., Farouk, H., Beekman, M. J.
npj Primary Care Respiratory Medicine, vol. 32, 37
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1038/s41533-022-00295-7
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/aa8f61ef-3e00-4a6f-90be-c17ea73ef1e8/download
Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs
2022 - Published
Leving, M., van Boven, J. F., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, E. S., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2401-2415
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.2147/COPD.S380736
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/2650d9a2-4c60-4bd2-b9f3-be70bd6a2883/download
Oral corticosteroids in asthma and beyond: moving forward
2022 - Published
Shi Kai Chan, J., Murray, R. B., Price, D.
European Respiratory Journal, vol. 60, no. 3, 2200776
Contributions to Journals: Editorials
- [ONLINE] DOI: https://doi.org/10.1183/13993003.00776-2022
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/44c37be4-dd68-49a4-900f-451c825858b4/download
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
2022 - Published
Chen, S., Miravitlles, M., Rhee, C. K., Pavord, I. D., Jones, R., Carter, V., Emmanuel, B., Alacqua, M., Price, D.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2187—2200
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.2147/COPD.S378649
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/6c2612e9-9128-4e71-a300-bb3091e2d0e1/download
Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study
2022 - Published
Al Zaabi, A., Mattarucco, W. J., Barriga, R. M., Wang, H., Diaz, D. V., Khattab, A., Pacheco Gallego, M., Farouk, H., Price, D.
European Respiratory Society (ERS) International Congress., pp. 2374
Contributions to Conferences: Abstracts
- [ONLINE] https://www.ers-education.org/lr/show-details/?idP=269195
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/dad2ad2c-b9cf-4f63-b409-dde4df56ff55/download
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
2022 - Published
Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H., Heaney, L. G., Carter, V., Chapaneri, J., Tran, T. N., Maslova, E., Price, D.
European Respiratory Society (ERS) International Congress., 4420
Contributions to Journals: Abstracts
- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2022.4420

... 19
20
21
22
23 ...

Show 10 | 25 | 50 | 100 results per page

Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study

Clinical Review: The suggested management pathway for urticaria in primary care

Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study

Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort

Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs

Oral corticosteroids in asthma and beyond: moving forward

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy

Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study

Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions